Our Evolution
Recent years have seen an explosion of discoveries around the diverse molecular and biological changes underlying cancer development and progression. These insights are changing the understanding of the complex pathways that regulate cancer cell biology, the interactions of cells with their microenvironment, and the mechanisms that restrain tumorigenesis. Importantly, researchers are translating these findings into innovative approaches toward cancer diagnosis, prognosis, and therapies.
Technical Summary
We have developed an innovative tumor tissue profiling platform called the GSProTM (Genetic Spatial Profiling) that transforms patient tumor biopsies into a deep, data-rich analysis for pre-clinical and clinical applications. In combination with our proprietary ONCOMaskTM technology and AI, we are developing a workflow that integrates digital pathology with genetic analysis to create a process that almost exclusively uses digital imaging to predict cancer patient response to drug therapy.
